A HYBRID ENERGY‐ AND AI‐BASED SCREENING FOR NOVEL INHIBITORS OF LCK FOR THE TREATMENT OF T‐CELL LYMPHOBLASTIC LYMPHOMA
Hang Guo(Second Affiliated Hospital of Jilin University), Keshu Zhou(Zhengzhou University), Huili Wang(Jinan University), Xingguang Liu(Naval Medical Research Command), Jie Yang(Chongqing University), Q. Zhang(Zhengzhou University), Zefeng Shen(Sir Run Run Shaw Hospital), Ying Liu(Zhengzhou University)
Cited by 0
Related Papers
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2022|453
The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation
|Journal of Neuroinflammation|2018|207
The Appropriate Marker for Astrocytes: Comparing the Distribution and Expression of Three Astrocytic Markers in Different Mouse Cerebral Regions
|BioMed Research International|2019|168
Evaluating the effects of mobile health intervention on weight management, glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus
|Journal of Endocrinological Investigation|2018|157
Autophagy induced by DAMPs facilitates the inflammation response in lungs undergoing ischemia-reperfusion injury through promoting TRAF6 ubiquitination
|Cell Death and Differentiation|2017|112